Peering Into Takeda Pharmaceutical's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Takeda Pharmaceutical's (NYSE:TAK) short interest has decreased by 6.67% since the last report, with 8.71 million shares sold short, representing 0.28% of available shares. The average time to cover these short positions is 3.53 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Takeda has a lower short interest compared to its peer group average of 3.25%.
November 21, 2023 | 4:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Takeda Pharmaceutical's short interest has decreased, which may suggest a more bullish sentiment among investors. The stock has less short interest than its peers, which could be perceived positively.
A decrease in short interest typically indicates that investors are less bearish on a stock, which could lead to a potential increase in its price in the short term. However, short interest is just one of many factors that can affect stock prices, and the impact may not be immediate or significant.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80